Stocks Surge To Start Week… And Structure Therapeutics CEO On Weight Loss Space 3/24/25

Stocks Surge To Start Week… And Structure The...

Up next

Micron Reports, Fed Holds Rates… And The Private Credit Ripple Effects 3/18/26

Micron shares on the move after earnings, and we break down what the results and guidance mean for the AI memory trade with S&P Global’s Melissa Otto. Plus, market reaction to the latest Fed rate decision, private-credit stress spills into consumer loans, and a spotlight on Josh ...  Show more

Strong Memory Momentum… And The Next Move For Retail Stocks 3/17/26

Storage stocks rallying to record highs, as demand for AI memory continues to climb. How much farther the group has to run, and what Nvidia CEO Jensen Huang said about the next evolution in the space. Plus The numbers out of Lululemon’s latest quarter, and where a top retail anal ...  Show more

Recommended Episodes

Dollar Drops, Gold Rises as Trump Ousts Fed's Cook
Bloomberg Daybreak: Asia Edition

The dollar dropped and gold gained after President Donald Trump removed Federal Reserve Governor Lisa Cook, raising concerns about the independence of the central bank. A gauge of the dollar retreated 0.3% as Cook will be removed from the position effective immediately, according ...  Show more

COVID-19 Vaccine Optimism, Business Leaders' Message To President Trump, And Retail Stocks' Big November Rally
Squawk on the Street

Kicking off a holiday-shortened week for the markets, Jim Cramer and David Faber highlighted the latest vaccine news to lift stocks: AstraZeneca announced that its COVID-19 vaccine being developed in conjunction with Oxford University was up to 90 percent effective with no ser ...

  Show more

Stocks Surge, Moderna Skyrockets, Goldman’s Blowout Quarter, Needham Ups Apple
Squawk on the Street

Carl Quintanilla, Jim Cramer and David Faber discuss the surge in stocks. Markets getting a boost from blowout results from Goldman Sachs and Moderna’s vaccine news. Goldman Sachs crushing earnings estimates its biggest outperformance in nearly a decade. Revenue was more than ...

  Show more

Fresnillo Gains, AstraZeneca Rebounds, Nexans Drops
Stock Movers

On this episode of Stock Movers: - Fresnillo gained on gold and silver's record highs as HSBC analysts raised its recommendation to hold from reduce. _ AstraZeneca rebound following a deal with the Trump administration to lower drug prices in the US in exchange for tariff relief. ...  Show more